- Home
- ARMP vs ELTK Comparison
ARMP vs ELTK Comparison
Compare ARMP & ELTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- ELTK
- Stock Information
- Founded
- ARMP N/A
- ELTK 1970
- Country
- ARMP United States
- ELTK Israel
- Employees
- ARMP N/A
- ELTK N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- ELTK Electrical Products
- Sector
- ARMP Health Care
- ELTK Technology
- Exchange
- ARMP Nasdaq
- ELTK Nasdaq
- Market Cap
- ARMP 80.0M
- ELTK 73.9M
- IPO Year
- ARMP N/A
- ELTK 1997
- Fundamental
- Price
- ARMP $2.11
- ELTK $11.14
- Analyst Decision
- ARMP Strong Buy
- ELTK
- Analyst Count
- ARMP 1
- ELTK 0
- Target Price
- ARMP $7.00
- ELTK N/A
- AVG Volume (30 Days)
- ARMP 8.2K
- ELTK 10.9K
- Earning Date
- ARMP 03-20-2025
- ELTK 03-10-2025
- Dividend Yield
- ARMP N/A
- ELTK 1.98%
- EPS Growth
- ARMP N/A
- ELTK N/A
- EPS
- ARMP N/A
- ELTK 0.85
- Revenue
- ARMP $5,467,000.00
- ELTK $48,090,000.00
- Revenue This Year
- ARMP $23.87
- ELTK $7.47
- Revenue Next Year
- ARMP N/A
- ELTK $9.96
- P/E Ratio
- ARMP N/A
- ELTK $13.10
- Revenue Growth
- ARMP 34.92
- ELTK 7.22
- 52 Week Low
- ARMP $1.80
- ELTK $9.00
- 52 Week High
- ARMP $4.48
- ELTK $14.52
- Technical
- Relative Strength Index (RSI)
- ARMP 56.44
- ELTK 47.59
- Support Level
- ARMP $1.85
- ELTK $11.05
- Resistance Level
- ARMP $2.08
- ELTK $11.60
- Average True Range (ATR)
- ARMP 0.12
- ELTK 0.40
- MACD
- ARMP 0.00
- ELTK -0.01
- Stochastic Oscillator
- ARMP 56.67
- ELTK 54.90
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnects. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.